Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Cash & Current Investments (2016 - 2025)

Milestone Scientific (MLSS) has disclosed Cash & Current Investments for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 66.67% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 66.67% year-over-year, with the annual reading at $1.1 million for FY2025, 66.67% down from the prior year.
  • Cash & Current Investments hit $1.1 million in Q4 2025 for Milestone Scientific, down from $1.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $17.0 million in Q1 2021 to a low of $1.1 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $7.6 million across 5 years, with a median of $5.9 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: soared 2112.96% in 2021 and later tumbled 77.4% in 2025.
  • Year by year, Cash & Current Investments stood at $14.8 million in 2021, then plummeted by 40.97% to $8.7 million in 2022, then crashed by 31.68% to $6.0 million in 2023, then tumbled by 44.58% to $3.3 million in 2024, then plummeted by 66.67% to $1.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for MLSS at $1.1 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.